Muscle Invasive Bladder Cancer Latest Advances

Find the Latest Research About Muscle Invasive Bladder Cancer

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1237 publications

Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state-of-the-art.

Bladder-preserving trimodality therapy for muscle-invasive bladder cancer: current state-of-the-art.

Journal: Expert review of anticancer therapy

Published: May 15, 2026

Are ctDNA and utDNA the New PSA for Clinically Localized Muscle Invasive Bladder Cancer in the Enfortumab Vedotin/Pembrolizumab Era?

Are ctDNA and utDNA the New PSA for Clinically Localized Muscle Invasive Bladder Cancer in the Enfortumab Vedotin/Pembrolizumab Era?

Journal: The Journal of urology

Published: April 29, 2026

Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study.

Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study.

Journal: Scientific reports

Published: April 06, 2026

Management of Intravesical Therapy-Related Lower Urinary Tract Symptoms - Leveraging Existing Options to Improve Outcomes.

Management of Intravesical Therapy-Related Lower Urinary Tract Symptoms - Leveraging Existing Options to Improve Outcomes.

Journal: The Journal of urology

Published: March 20, 2026

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Journal: BJU international

Published: March 13, 2026

Diagnostic accuracy and reliability of VI-RADS in assessing muscle invasion in bladder cancer: Insight from a prospective tertiary care study.

Diagnostic accuracy and reliability of VI-RADS in assessing muscle invasion in bladder cancer: Insight from a prospective tertiary care study.

Journal: Urologia

Published: March 13, 2026

Nanoparticles-mediated dual metabolic-immunological intervention reverses immunosuppression in muscle invasive bladder cancer.

Nanoparticles-mediated dual metabolic-immunological intervention reverses immunosuppression in muscle invasive bladder cancer.

Journal: Biomaterials

Published: March 06, 2026

KRT14 Drives Basal Muscle-Invasive Bladder Cancer Progression and Lung Metastasis by Directly Binding to and Stabilizing IGF2BP1.

KRT14 Drives Basal Muscle-Invasive Bladder Cancer Progression and Lung Metastasis by Directly Binding to and Stabilizing IGF2BP1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 15, 2026

The Role of Socioeconomic Status in Influencing Stage at Presentation and Overall Survival in Bladder Cancer: Experience From the West of Scotland.

The Role of Socioeconomic Status in Influencing Stage at Presentation and Overall Survival in Bladder Cancer: Experience From the West of Scotland.

Journal: Cureus

Published: February 10, 2026

The challenge of bladder preservation in muscle invasive bladder cancer: key concepts and future directions.

The challenge of bladder preservation in muscle invasive bladder cancer: key concepts and future directions.

Journal: Current opinion in urology

Published: February 09, 2026

Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer.

Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: February 08, 2026

Super-selective bladder arterial chemotherapy for muscle invasive bladder cancer.

Super-selective bladder arterial chemotherapy for muscle invasive bladder cancer.

Journal: Translational andrology and urology

Published: January 20, 2026

Showing 1-12 of 1,237

Last Updated: 06/30/2026